You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A daily client check-in system for outpatient substance abuse treatment
SBC: COG ANALYTICS, LLC Topic: NIDAAbstract Alcohol and illicit drug use remain highly prevalent in the US, and epidemiological surveillance surveys estimate that over 20.6 million individuals (~ 8% of the US population) meet standard diagnostic thresholds for substance use disorders (SAMHSA, 2011). Outpatient substance abuse treatment is the predominate method of treatment in the US for SUDs, typically involving intermittent cont ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Advanced Light Extraction Material for OLED Lighting
SBC: Pixelligent Technologies, LLC Topic: 13cOne of the major hurdles to the commercialization of OLED lighting technology is its low light extraction efficiency when compared to its inorganic LEDs. Currently only 20 30% of the light produced by the OLED can be extracted. In order to be considered as a commercially viable option, OLED lighting efficacy has to improve dramatically. The mismatch between the refractive indices among the activ ...
SBIR Phase I 2014 Department of Energy -
A Millimeter-wave Tunable Cavity for Ultra-sensitive Solids and Liquids DNP-NMR at Low Budget
SBC: DOTY SCIENTIFIC, INC. Topic: NIA? DESCRIPTION (provided by applicant): NMR is probably the most powerful and widely used analytical technique for structure determination and function elucidation of molecules of all types, but it suffers from low sensitivity, particularly for insoluble biological macromolecules. Dynamic Nuclear Polarization (DNP) with Magic Angle Spinning (MAS) has recently demonstrated S/N gains exceeding t ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC
SBC: PROFECTUS BIOSCIENCES, INC. Topic: RDESCRIPTION Based on the prevailing evidence we believe that a highly effective vaccine for HIV prophylaxis must induce long lasting broadly cross reactive antibody responses to envelope that exhibit antiviral activity as well as multi antigen polyfunctional CD and CD T cell responses that produce antiviral chemokines and cytokines and are possibly biased towards an effector memory phenot ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A simple assay system for rapid detection of circulating tumor cells
SBC: TELOVISION, LLC Topic: NCIDESCRIPTION provided by applicant Metastasis or dissemination of primary tumor cells is the major cause of mortality in cancer patients Circulating tumor cells CTCs in the bloodstream are key players in the establishment of metastatic tumors Recent studies demonstrated that the number of CTCs present in patient blood directly correlate with cancer progression recurrence and survival rate ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Automating mosquito microdissection for a malaria PfSPZ vaccine
SBC: SANARIA INC. Topic: NIAIDDESCRIPTION Malaria causes andgt million clinical cases and million deaths annually is responsible for andgt loss of GDP in Africa and is a serious concern for travelers and military personnel A highly effective vaccine is desperately needed and radiation attenuated Plasmodium falciparum Pf sporozoites SPZ and non attenuated PfSPZ with chloroquine chemoprophylaxis ChemoProphylax ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Biomarker Breast Pap Test
SBC: SILBIOTECH, INC. Topic: NCIDESCRIPTION (provided by applicant): This Phase I research proposal is to investigate the feasibility of developing a novel Biomarker Breast PapTest for screening Nipple Aspirate Fluid (NAF) and detecting breast cancers at the tumor-in-formation stage before mammographically detectable tumors are developed. Although there is a slight decline in deaths from breast cancer in recent years, it conti ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Building an open-source cloud-based computational platform to improve data access
SBC: BIODATOMICS, LLC Topic: NIDAWe propose to develop a novel, cost-effective, cloud-based data and analytics platform that will provide efficient data storage solutions and enhanced analytics, annotation and reporting capabilities for supporting and accelerating clinical and molecular research in the treatment of substance use disorders (SUD). This open source platform, which leverages existing BioDX technology, will provide a ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Cerberus-LNR: A Tethered Lightfield 3D Endoscope for Advanced Minimally Invasive
SBC: XIGEN, LLC Topic: NIDDKDESCRIPTION (provided by applicant): The primary objective of this SBIR is to develop and pre-clinically evaluate a novel lightfield 3D endoscope, dubbed Cerberus-LNR, specially designed for laparoendoscopic single-site surgery (LESS), natural orifice translumenal endoscopic surgery (NOTES), and robotic LESS (R-LESS) (hereafter LNR) procedures. The miniature Cerberus-LNR lightfield 3D endoscope co ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Clinical Development of IPdR for Radiosensitization Period of Performance: 09/19/2014- 06/18/2015
SBC: Shuttle Pharmaceuticals, Inc. Topic: NCIThe objective of this fast-track SBIR Application is to advance commercialization efforts for IPdR (5-iodo-2pyrimidinone-2'-deoxyribose), a prod rug of the radiosensitizer IUdR (5-iodo-2'-deoxyuridine). In the Phase I SBIR, we will determine the scientific merit, feasibility and potential for commercialization of oral lPdR as a radiation sensitizer for use in cancer treatment. Administrative tasks ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health